Is ICU Medical, Inc. (ICUI)’s Fuel Running Low? The Stock Reaches 52-Week High Today

May 17, 2018 - By James Guidry

ICU Medical, Inc. (NASDAQ:ICUI) Logo

Investors sentiment increased to 1.19 in Q4 2017. Its up 0.33, from 0.86 in 2017Q3. It increased, as 11 investors sold ICU Medical, Inc. shares while 75 reduced holdings. 36 funds opened positions while 66 raised stakes. 15.21 million shares or 2.37% less from 15.58 million shares in 2017Q3 were reported.
Comerica Bancorporation owns 23,072 shares. Moreover, State Board Of Administration Of Florida Retirement has 0% invested in ICU Medical, Inc. (NASDAQ:ICUI). Deutsche Bank & Trust Ag owns 34,631 shares. American Grp has 11,968 shares. Proshare Advsr Lc has 0% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 2,693 shares. Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 984 shares. Principal Group Incorporated stated it has 0.02% in ICU Medical, Inc. (NASDAQ:ICUI). Pura Vida Invs Lc has invested 5.6% in ICU Medical, Inc. (NASDAQ:ICUI). Plante Moran Advsrs Ltd Liability Co accumulated 4 shares or 0% of the stock. The Minnesota-based Thrivent Financial For Lutherans has invested 0.01% in ICU Medical, Inc. (NASDAQ:ICUI). Tci Wealth Advisors stated it has 5 shares or 0% of all its holdings. Glenmede Trust Com Na owns 169,678 shares. Teacher Retirement System Of Texas reported 5,503 shares. Markston Interest Ltd Liability accumulated 100 shares. Moreover, Royal Natl Bank Of Canada has 0.01% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 152,395 shares.

Since January 4, 2018, it had 0 buys, and 9 selling transactions for $31.12 million activity. $1.65M worth of stock was sold by LOPEZ GEORGE A on Thursday, April 5. The insider Sanzone Virginia Ruth sold 500 shares worth $134,925. 23,624 shares were sold by Lamb Scott E, worth $5.20 million. SAUCEDO JOSEPH R had sold 1,566 shares worth $421,285 on Monday, May 14.

The stock of ICU Medical, Inc. (NASDAQ:ICUI) hit a new 52-week high and has $282.68 target or 3.00 % above today’s $274.45 share price. The 7 months bullish chart indicates low risk for the $5.57B company. The 1-year high was reported on May, 17 by Barchart.com. If the $282.68 price target is reached, the company will be worth $167.16 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.55% or $1.5 during the last trading session, reaching $274.45. About 52,940 shares traded. ICU Medical, Inc. (NASDAQ:ICUI) has risen 61.26% since May 17, 2017 and is uptrending. It has outperformed by 49.71% the S&P500.

Analysts await ICU Medical, Inc. (NASDAQ:ICUI) to report earnings on August, 8. They expect $1.45 earnings per share, up 178.85 % or $0.93 from last year’s $0.52 per share. ICUI’s profit will be $29.44M for 47.32 P/E if the $1.45 EPS becomes a reality. After $2.06 actual earnings per share reported by ICU Medical, Inc. for the previous quarter, Wall Street now forecasts -29.61 % negative EPS growth.

More important recent ICU Medical, Inc. (NASDAQ:ICUI) news were published by: Ocbj.com which released: “Midday Stock Roundup” on May 10, 2018, also Benzinga.com published article titled: “Earnings Scheduled For May 9, 2018”, Globenewswire.com published: “ICU Medical, Inc. Announces First Quarter 2018 Results” on May 09, 2018. More interesting news about ICU Medical, Inc. (NASDAQ:ICUI) was released by: Seekingalpha.com and their article: “ICU Medical’s (ICUI) CEO Vivek Jain on Q1 2018 Results – Earnings Call Transcript” with publication date: May 10, 2018.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. The company has market cap of $5.57 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patientÂ’s vein for use in hospitals and ambulatory clinics. It has a 83.42 P/E ratio. The companyÂ’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

ICU Medical, Inc. (NASDAQ:ICUI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: